Merck & Co., Inc. (MRK) News Today

Capital International Investors lifted its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 3,714.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,023,853 shares of the company's stock after buying an a

Merck & Co., Inc. (NYSE:MRK) declared a quarterly dividend on Wednesday, July 24th. Investors of record on Monday, September 16th will be paid a dividend of 0.77 per share on Monday, October 7th. This represents a $3.08 annualized dividend and a dividend yield of 2.45%. The ex-dividend date is Monday, September 16th.

Merck & Co., Inc. (NYSE:MRK) will be releasing earnings before the market opens on Tuesday, July 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=375150)

Acadian Asset Management LLC boosted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 105.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 164,863 shares of the company's stock after purchasing an additional 84,5

Connors Investor Services Inc. lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 5.9% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 122,263 shares of the company's stock after selling 7,638 sha

M&G Plc purchased a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 370,610 shares of the company's stock, valued at approximately $48,921,000. Other hedge funds

ProVise Management Group LLC decreased its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 32.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,190 shares of the company's stock after selling 4,324 shares du

Merck & Co., Inc. (NYSE:MRK - Get Free Report) saw unusually large options trading activity on Friday. Traders acquired 46,428 call options on the company. This represents an increase of approximately 97% compared to the average volume of 23,534 call options.

BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 40.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,509,332 shar

Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.

Avantax Advisory Services Inc. grew its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 19.2% during the first quarter, according to its most recent filing with the SEC. The firm owned 138,465 shares of the company's stock after acquiring an additional 22,289 shares during the p

NorthRock Partners LLC lifted its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 27.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 31,495 shares of the company's stock after purchasing an additional 6,855 shares during

IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather

Swiss National Bank reduced its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 4.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,588,751 shares of the company's stock after selling 345,900 shares during

Capital Wealth Planning LLC reduced its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 9.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,267,952 shares of the company's stock after selling 2

Quantbot Technologies LP raised its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 199.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 91,444 shares of the company's stock after purchasing an additional 60,867

FDx Advisors Inc. trimmed its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 36.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,424 shares of the company's stock after selling 21,676 shares during

Easterly Investment Partners LLC trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 28.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 95,627 shares of the company's stock after selling 37,61

Drug prices continue to rise, driving up healthcare costs. Pharmaceutical companies usually hike drug prices at the beginning of each year. In January 2024

Daiwa Securities Group Inc. increased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 9.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 351,376 shares of the company's stock after acquiring an additional 30,387 s

Jennison Associates LLC lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,580,395 shares of the company's stock after selling 20,623 shares during

BNP Paribas purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 314,573 shares of the company's stock, valued at approximately $40,893,000. Merck & Co.,

Sequoia Financial Advisors LLC reduced its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 6.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 159,096 shares of the company's stock after selling 10,864

Hartline Investment Corp purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 34,885 shares of the company's stock, valued at approximately $4,6

American National Bank & Trust Co. VA purchased a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 54,867 shares of the company's stock, valued at

Svenska Handelsbanken AB publ purchased a new position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm purchased 200,000 shares of the company's stock, valued at approximately $26,390,000. Merck & Co., Inc.